Clinical Trials Browser

Phase NA × Endocrine × 90 days × Clear all

NCT06629220 2026-04-14

Co-creation of Tools for Men With Suicidal Thoughts and/or Behavior

Phase NA Completed

Suicide Prevention, Multiple Endocrine Neoplasia Type 1, Suicidal Ideation

NCT07529080 2026-04-14

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

Phase NA Not yet recruiting

DermatologicEndocrineGenitourinaryHead & Neck

Thyroid Cancer, Papillary, Melanoma, Testicular Neoplasms, Adenocarcinoma, Follicular

NCT03678389 2026-04-13

Feasibility of Endosphenoidal Coil Placement for Imaging of the Sella During Transsphenoidal Surgery

Phase NA Recruiting

Pituitary Neoplasms

NCT04569591 2026-04-09

DDAVP for Pituitary Adenoma

Phase NA Recruiting

Pituitary Neoplasms, Pituitary ACTH Hypersecretion

NCT06141369 2026-04-09

Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)

Phase NA Recruiting

Adenoma, Islet Cell, Adrenocortical Carcinoma, Carcinoma, Medullary

NCT07247526 2026-04-09

Effect of Foot Bath on Anxiety and Physiological Parameters

Phase NA Completed

Anxiety Disorders, Pituitary Neoplasms

NCT06826170 2026-03-30

HYPOADENO

Phase NA Completed

Pituitary Neoplasms

NCT07377487 2026-03-30

INDIGO

Phase NA Recruiting

EndocrineGastrointestinalNET

Carcinoma, Colonic Diseases, Digestive System Diseases, Digestive System Neoplasms, Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms, Neoplasm Metastasis, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Glandular and Epithelial, Colorectal Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04074642 2026-03-24

FIRST

Phase NA Completed

Pituitary Neoplasms

NCT04804371 2026-03-23

Dual Tracer (68Ga-DOTATATE and 18F-FDG) PET Imaging in G2 & G3 Gastroenteropancreatic Neuroendocrine Tumors

Phase NA Active not recruiting

Neuroendocrine Tumors

NCT07470580 2026-03-13

ADERADHTA2

Phase NA Not yet recruiting

Hyperaldosteronism, Hypertension, Hypokalemia, Adrenocortical Adenoma

NCT04175678 2026-03-10

Project 1: Diet and Exercise Modulate the Sperm Epigenome in Men

Phase NA Active not recruiting

Motor Activity, Obesity, Multiple Endocrine Neoplasia Type 1

NCT07458906 2026-03-09

DLL3-Targeted PET/CT in Neuroendocrine Carcinoma

Phase NA Recruiting

Carcinoma, Neuroendocrine

NCT05604963 2026-03-05

HoT

Phase NA Recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT03416686 2026-02-25

METATHYRAF

Phase NA Active not recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT07068542 2026-02-24

TROPION

Phase NA Recruiting

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

NCT04907643 2026-02-20

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

Phase NA Recruiting

EndocrineGastrointestinalNET

Cancer Pain, Anus Neoplasms, Appendiceal Neoplasms, Bile Duct Neoplasms, Biliary Tract Neoplasms, Carcinoid Tumor, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Gastrointestinal Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Rectal Neoplasms, Recurrence, Stomach Neoplasms, Neuroendocrine Tumors, Visceral Pain

NCT04278118 2026-02-17

HiPPI

Phase NA Recruiting

Brain Neoplasms, Meningioma, Neurilemmoma, Pituitary Neoplasms, Nerve Sheath Neoplasms

NCT07412782 2026-02-17

REMS25: Study on the Use of REMS Technology in Diseases Commonly Associated With Reduced Bone Mineral Density (BMD)

Phase NA Recruiting

Bone Diseases, Metabolic, Cushing Syndrome, Dwarfism, Pituitary, Neoplasms, Obesity, Osteogenesis Imperfecta, Osteoporosis, Malnutrition, Overweight

NCT01022515 2026-02-06

PHEO

Phase NA Completed

Essential Hypertension, Hypertension, Paraganglioma, Pheochromocytoma

NCT05139277 2026-02-06

Evaluation of the CONVIVO System

Phase NA Recruiting

Brain Neoplasms, Glioblastoma, Glioma, Meningioma, Neurilemmoma, Pituitary Neoplasms

NCT05599139 2026-02-06

IULID

Phase NA Recruiting

EndocrineHead & Neck

Differentiated Thyroid Cancer

NCT04104529 2026-02-05

BCB RIV

Phase NA Recruiting

EndocrineGenitourinaryHead & NeckNET

Prostatic Neoplasms, Thyroid Neoplasms, Neuroendocrine Tumors

NCT06235814 2026-02-05

MAPS

Phase NA Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT06297473 2026-01-29

PITCARE

Phase NA Enrolling by invitation

Non-Functional Pituitary Adenoma

NCT07376837 2026-01-29

PTC-RFA

Phase NA Not yet recruiting

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT05014698 2026-01-28

IDENTHY-K

Phase NA Terminated

EndocrineHead & Neck

Thyroid Cancer, Papillary

NCT06954909 2026-01-28

The Impact of Self-assessment on Hydration

Phase NA Enrolling by invitation

Multiple Endocrine Neoplasia Type 1

NCT07373015 2026-01-28

Modified Double Snare Assisted EMR (mDS-EMR) VS ESD for Rectal Neuroendocrine Tumors Smaller Than 1cm

Phase NA Not yet recruiting

EndocrineGastrointestinalNET

Rectal Neuroendocrine Tumors

NCT06620419 2026-01-27

Clinical Study of External Electrical Stimulation for Male Incontinence

Phase NA Active not recruiting

Urinary Incontinence, Multiple Endocrine Neoplasia Type 1

NCT02826928 2026-01-21

Diagnostic Performances of Urine and Plasma 5-hydroxyindolacetic Acid (5HIAA) Values in Patients With Small-intestine Neuroendocrine Tumors

Phase NA Completed

Carcinoid Tumor